Portal for patients

Healthcare Industry News

About everything that happens with the clinics, medical and diagnostic centers, laboratories, pharmacies and cosmetic companies , as well as any other medical institutions of the country and the world. 

A New Drug For The Treatment Of Obesity Entered The U.S. Market
Food and Drug Administration (FDA) has allowed the use of hypoglycemic agent liraglutide as anti-obesity drug. Developed by Novo Nordisk, it…
Some Companies Are Planning To Open Production Facilities In St. Petersburg Pharmaceutical Cluster
Several innovative- industrial complexeswill be opened on the territory of St. Petersburg pharmaceutical cluster next year. This was told by…
​GlaxoSmithKline Has Successfully Tested A Vaccine Against Shingles
GlaxoSmithKline reported positive results with phase III clinical trials of the drug for the prevention of shingles. As evidenced by the…
​Bayer Was Unable To Defend Patent Rights  For Sorafenib In India
German pharmaceutical producer Bayer failed to block the access to the Indian market of its generic anti-tumor agent Nexavar (sorafenib). The…
​Merck Announced The Purchase Of Cubist
Merck & Co has officially announced the acquisition of Cubist Pharmaceuticals for 8.4 billion dollars. Also, under the terms of the…
Abbott Can Acquire Russian Veropharm By The End Of The Year
The deal forthe acquision of Russian pharmaceutical company Veropharm by American Abbott company can be closed by the end of this year. This…
​GlaxoSmithKline Received Approval For The Purchase Of Novartis Vaccine Business Servicess
Antimonopoly Service has approved the acquisition of Novartis vaccine division, except the medicine against flu by GlaxoSmithKline.The…
​Bayer AG Is Selling the Division for Production of Medical Equipment For Patients With Diabetes
German pharmaceutical producer Bayer AG is considering new options for the sale of their unit engaged in the production of devices for…
AbbVie Bought The Factory In Singapore
AbbVie announced the acquisition of biopharmaceutical production in Singapore Technology Park Tuas Biomedical. The purchase of a factory for…
FDA Approved The Use Of Alemtuzumab In The Treatment Of Relapsing Multiple Sclerosis
Food and Drug Administration (FDA) has registered alemtuzumab (Lemtrada) for the treatment of relapsing multiple sclerosis (MS). According to…
Application for treatment
Sex
MTEC 2019 (eng.-com)